ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NVST vs PLSE // EV/EBITDA & P/E VALUATION

Envista Holdings Corporation (NYSE) VS. Pulse Biosciences Inc (NASDAQ) • 15-METRIC TALLY: NVST 7 — PLSE 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVST VS. PLSE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NVST PLSE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 54.70% -30.00% +84.70 NVST /gross-margins <GO>
Return on Invested Capital (ROIC) 5.10% -30.70% +35.80 NVST /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 16.5x — — TIE /valuation <GO>
Free Cash Flow Yield 5.83% -1.38% +7.21 NVST /fcf-yield <GO>
Operating Margin 7.90% -60.00% +67.90 NVST /operating-margins <GO>
Net Profit Margin 1.70% -60.00% +61.70 NVST /net-margins <GO>
Revenue Growth (YoY) 8.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.61 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 9/9 2/9 +7.00 NVST /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.8 53.1 +3.70 NVST /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.93 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 78.2x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.95B $3.96B -$4.2M PLSE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NVST REV PLSE REV NVST GROSS % PLSE GROSS % NVST FCF PLSE FCF
FY 2025 $2.72B $350.0K 54.7% -50.0% $230.4M -$54.4M
FY 2024 $2.51B $0 54.7% — $302.7M -$36.5M
FY 2023 $2.57B $0 — — $160.2M -$33.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVST // BETA 0.93
PLSE // BETA —